This article was originally published in The Gray Sheet
Expects to report a third quarter loss "on significantly lower revenue," according to an April 5 release. The firm cites "the unsettled outlook for health care reform," lower gross margins and the "continuing impact of absorbing the cost of improvements" to its installed base of PLTL-1 lasers, which are being modified because of "reliability problems." The device is used to remove pigmented lesions and tattoos. For the second quarter ended Jan. 2, the firm reported earnings of $24,000 (down 95.7%) on sales of $9.9 mil. (up 16.5%).
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.